Advanced search×

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.

JAMA 305(14):1460-8 (2011) PMID 21486979

Short-term data on the immunogenicity of monoclonal antibodies showed associations between the development of antidrug antibodies and diminished serum drug levels, and a diminished treatment response. Little is known about the clinical relevance of antidrug antibodies against these drugs during long-term follow-up. To examine the course of antidrug antibody formation against fully human monoclonal antibody adalimumab and its clinical relevance during long-term (3-year) follow-up of patients with rheumatoid arthritis (RA). Prospective cohort study February 2004-September 2008; end of follow-up was September 2010. All 272 patients were diagnosed with RA and started treatment with adalimumab in an outpatient clinic. Disease activity was monitored and trough serum samples were obtained at baseline and 8 time points to 156 weeks. Serum adalimumab concentrations and antiadalimumab antibody titers were determined after follow-up. Treatment discontinuation, minimal disease activity, and clinical remission were compared for patients with and without antiadalimumab antibodies. After 3 years, 76 of 272 patients (28%) developed antiadalimumab antibodies--51 of these (67%) during the first 28 weeks of treatment. Patients without antiadalimumab antibodies had much higher adalimumab concentrations (median, 12 mg/L; IQR, 9-16 mg/L) compared with patients with antibody titers from 13 to 100 AU/mL (median, 5 mg/L; IQR, 3-9 mg/L; regression coefficient, -4.5; 95% CI, -6.0 to -2.9; P

Version: za2963e q8zab q8zb8 q8zca q8zd6 q8zea q8zf5 q8zg6

Similar articles you may find interesting…

  1. A Novel Bioassay for Anti-Tsh Receptor Autoantibodies Detects Both Thyroid-Blocking and Stimulating Activity.

    Clin Exp Immunol (2013) PMID 23647395

    We developed a TBAb bioassay based on a cell line that expresses a chimeric TSHR. The 50% inhibitory concentration of the chimeric CHO-Luc cells was over 5-fold lower compared with the wild-type-CHO-Luc cells. We tested the performance of this bioassay using a thyroid-blocking monoclonal antibody K1...
  2. In vitro and in vivo antidermatophytic activity of the dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva Hier...

    BMC Complement Altern Med 13(1):95 (2013) PMID 23641972

    The results of preclinical in vitro and in vivo evaluations indicate that the extract-oil formulation at 5% may constitute an alternative means to alleviate fungal infections caused by dermatophytes....
  3. Virological and Immunological Characteristics of Human Cytomegalovirus Infection Associated with Alzheimer's Disease.

    J Infect Dis (2013) PMID 23661800

    Serum, CSF and cryopreserved lymphocytes from subjects in the Rush Alzheimer's Disease Center Religious Orders Study were analyzed for associations between CMV infection and clinical and pathological markers of Alzheimer's Disease (AD). CMV antibody levels were associated with neurof...